Engrave Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-32
Closed -$8K 171
2020
Q2
$8K Sell
32
-9
-22% -$2.4K 0.01% 268
2020
Q1
$9K Sell
41
-20
-33% -$5.45K 0.01% 217
2019
Q4
$18K Buy
+61
New +$16.8K 0.02% 233

Other funds holding ELV

Engrave Wealth Partners's ELV Position: Q3 2020 in Review

Engrave Wealth Partners sold out of Elevance Health (ELV) in Q3 2020, closing a stake of 32 shares — an estimated $8K sold.

Engrave Wealth Partners first reported a position in ELV in Q4 2019 and held it in 3 quarters. The position peaked at $18K in Q4 2019. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • Engrave Wealth Partners reported no remaining Elevance Health position as of Q3 2020 after selling out during the quarter.
  • Engrave Wealth Partners sold 32 Elevance Health shares in Q3 2020, an estimated $8K.
  • Engrave Wealth Partners first reported a position in Elevance Health in Q4 2019 and held it in 3 quarters.
  • Engrave Wealth Partners's Elevance Health position peaked at $18K in Q4 2019.
  • 1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on Engrave Wealth Partners's 13F filing for Q3 2020, filed 8 Oct 2020.